From sophisticated imaging tools to cancer-sniffing dogs, researchers are constantly seeking better ways to detect disease, which could lead to earlier and more effective treatment. In recent years, genetically manipulated bacteria seemed like promising indicators, but they never made it to the clinical setting because they couldn’t reliably distinguish important chemical signals in complex samples. Now, two research teams have engineered E. colibacteria to accurately detect the telltale chemical signs of diabetes and liver cancer in urine. The two studies were published today in Science Translational Medicine.
via Popular Science
May 27, 2015
featured blogs
Mar 18, 2024
Innovation in the AI and supercomputing domains is proceeding at a rapid pace, with each new advancement heralding a future more tightly interwoven with the threads of intelligence and computation. Cadence, with the release of its Millennium Platform, co-optimized with NVIDIA...
Mar 18, 2024
Cloud-based EDA tools are critical to accelerating AI chip design and verification; see how NeuReality leveraged cloud-based chip emulation for their 7NR1 NAPU.The post NeuReality Accelerates 7nm AI Chip Tape-Out with Cloud-Based Emulation appeared first on Chip Design....
Mar 5, 2024
Those clever chaps and chapesses at SiTime recently posted a blog: "Decoding Time: Why Leap Years Are Essential for Precision"...